Affect, Social Behavior and Communication Among Children Prenatally Exposed to Oxytocin Receptor Antagonists
E. Friedlander D. Mankuta M. Yaari A. Harel R. Ebstein N. Yirmiya

Lessons Learned from Phase I Proof-of-Mechanism and Biomarker Studies in ASD: Measurement and Trial Considerations
J. T. McCracken E. Hollander L. Scahill M. del Valle Rubido F. Shic O. Khwaja L. Squassante S. Sadikhov L. Boak F. Bolognani P. Fontoura C. A. Wall R. J. Jou R. L. Loomis M. C. Lyons A. Gavaletz C. J. Ferretti B. P. Taylor G. Berlin R. Noone L. N. Antar D. Umbricht

Effects of Intranasal Oxytocin on Systemizing and Empathizing Tasks in Children with and without Autism
L. Strathearn S. Kim U. Iyengar S. Martinez P. Fonagy

A New Vasopressin V1a Antagonist Restores Normal Social Behavior and Reveals a Specific Brain Network in the Rat Valproate Model of Autism
C. Grundschober T. Mueggler F. Knoflach C. Risterucci P. Schnider B. Biemans